Najwa El-Nachef

发表

Anti-Tumor Necrosis Factor Therapy for Inflammatory Bowel Disease in the Setting of Immunosuppression for Solid Organ Transplantation

J. Terdiman, U. Mahadevan, Najwa El-Nachef, 2010, The American Journal of Gastroenterology.

Fecal microbiota transplant for Crohn disease: A study evaluating safety, efficacy, and microbiome profile

S. Lynch, D. Fadrosh, J. Terdiman, 2019, United European gastroenterology journal.

New-Onset of Inflammatory Bowel Disease in a Patient Treated With Teprotumumab for Thyroid Associated Ophthalmopathy

Grace E. Kim, R. Kersten, B. Winn, 2021, Ophthalmic plastic and reconstructive surgery.

CLINICAL CHALLENGES AND IMAGES IN GI An Unusual Mechanical Cause of Upper Gastrointestinal Hemorrhage.

N. Ha, Najwa El-Nachef, Connie W. Wang, 2020, Gastroenterology.

Fecal microbiota transplantation for the treatment of recurrent and severe Clostridium difficile infection in solid organ transplant recipients: A multicenter experience

Huiping Xu, D. Kao, Z. Kassam, 2018, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

S131 CP101, an Investigational Orally Administered Microbiome Therapeutic, Increases Intestinal Microbiome Diversity and Prevents Recurrent C. difficile Infection: Results From a Randomized, Placebo-Controlled Trial

T. Borody, C. Kelly, D. Pardi, 2021, American Journal of Gastroenterology.

S144 CP101 Engraftment Drives Efficacy: Results From a Randomized, Placebo-Controlled Trial Evaluating CP101, an Investigational Orally Administered Microbiome Therapeutic for Prevention of Recurrent C. difficile Infection

T. Borody, C. Kelly, D. Pardi, 2021, American Journal of Gastroenterology.

S145 Week 24 Efficacy and Safety Data from PRISM3: A Randomized, Placebo-Controlled Trial Evaluating CP101, an Investigational Orally Administered Microbiome Therapeutic for the Prevention of Recurrent C. difficile Infection

T. Borody, C. Kelly, D. Pardi, 2021, American Journal of Gastroenterology.

Strain-resolved analysis in a randomized trial of antibiotic pretreatment and maintenance dose delivery mode with fecal microbiota transplant for ulcerative colitis

K. Pollard, S. Lynch, J. Terdiman, 2022, Scientific Reports.

Clinical efficacy and increased donor strain engraftment after antibiotic pretreatment in a randomized trial of ulcerative colitis patients receiving fecal microbiota transplant

Byron J. Smith, K. Pollard, S. Lynch, 2021, medRxiv.

Fecal microbial therapy: promises and pitfalls.

S. Lynch, D. Merenstein, Najwa El-Nachef, 2014, Journal of pediatric gastroenterology and nutrition.

Fecal Microbiota Transplantation in Pouchitis: Clinical, Endoscopic, Histologic, and Microbiota Results from a Pilot Study

S. Lynch, D. Fadrosh, J. Terdiman, 2019, Digestive Diseases and Sciences.

Fecal Microbiota Transplantation is Safe and Effective in Patients with Clostridioides difficile Infection and Cirrhosis.

A. Khoruts, G. Ianiro, Huiping Xu, 2020, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Fecal Microbiota Transplantation is Safe and Effective in Chronic Pouchitis Patients

S. Lynch, J. Terdiman, Z. Kassam, 2017 .

Su1747 Fecal Microbiota Transplant Improves Symptoms in Patients with Pouchitis and Induces Changes in the Microbiome: Preliminary Results of an Open Label Trial

S. Lynch, J. Terdiman, Kaitlyn S. Lucey, 2016 .

Adherence to colorectal cancer screening: a randomized clinical trial of competing strategies.

Angela Fagerlin, Rodney A Hayward, Sandeep Vijan, 2012, Archives of internal medicine.

36 ANTIBIOTIC PRETREATMENT PRIOR TO FECAL MICROBIOTA TRANSPLANTATION INCREASES RATES OF REMISSION IN PATIENTS WITH MILD TO MODERATE ULCERATIVE COLITIS: RESULTS FROM A PILOT RANDOMIZED CLINICAL TRIAL

Byron F. Smith, S. Lynch, J. Terdiman, 2020 .

Capsule-Delivered Fecal Microbiota Transplant Is Safe and Well Tolerated in Patients with Ulcerative Colitis

J. Terdiman, Z. Kassam, M. Zydek, 2019, Digestive Diseases and Sciences.

Multicenter Real-world Experience of Upadacitinib in the Treatment of Crohn's Disease.

E. Loftus, J. Terdiman, S. Kane, 2022, Journal of Crohn's & Colitis.

Fecal microbial transplant for inflammatory bowel disease

J. Claytor, Najwa El-Nachef, 2020, Current opinion in clinical nutrition and metabolic care.

The Current Landscape and Lessons from Fecal Microbiota Transplantation for Inflammatory Bowel Disease: Past, Present, and Future

C. Kelly, Z. Kassam, J. Allegretti, 2017, Inflammatory bowel diseases.

The Role of Fecal Microbiota Transplantation in Ulcerative Colitis and Crohn's Disease: Results from a Parallel Inflammatory Bowel Disease Cohort Study

S. Lynch, D. Fadrosh, J. Terdiman, 2017 .

Effect of I‐scan Electronic Chromoendoscopy on Detection of Adenomas During Colonoscopy

J. Terdiman, Jeffrey-K Lee, Michael G. Kattah, 2019, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

THE EFFECT OF INDIVIDUALIZED FEEDBACK ON LEARNING CURVES IN EGD AND COLONOSCOPY: A CLUSTER RANDOMIZED CONTROLLED TRIAL.

Robert H. Lee, Swati G. Patel, Mohit Mittal, 2019, Gastrointestinal endoscopy.

Changing perceptions and practices regarding aspirin, nonsteroidal anti‐inflammatory drugs, and cyclooxygenase‐2 selective nonsteroidal anti‐inflammatory drugs among US primary care providers

W. Chey, A. Fendrick, J. Scheiman, 2008, Alimentary pharmacology & therapeutics.